These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21903000)

  • 21. Evidence-based assessment: evaluation of the formocresol versus ferric sulfate primary molar pulpotomy.
    Loh A; O'Hoy P; Tran X; Charles R; Hughes A; Kubo K; Messer LB
    Pediatr Dent; 2004; 26(5):401-9. PubMed ID: 15460294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term effectiveness of four pulpotomy techniques: 3-year randomised controlled trial.
    Huth KC; Hajek-Al-Khatar N; Wolf P; Ilie N; Hickel R; Paschos E
    Clin Oral Investig; 2012 Aug; 16(4):1243-50. PubMed ID: 21842145
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of folk medicinal plant extract Ankaferd Blood Stopper(®) in vital primary molar pulpotomy.
    Yaman E; Görken F; Pinar Erdem A; Sepet E; Aytepe Z
    Eur Arch Paediatr Dent; 2012 Aug; 13(4):197-202. PubMed ID: 22883359
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferric sulphate and formocresol in pulpotomy of primary molars: long term follow-up study.
    Ibricevic H; Al-Jame Q
    Eur J Paediatr Dent; 2003 Mar; 4(1):28-32. PubMed ID: 12870985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Formocresol pulpotomies in primary molars: a radiographic study in a pediatric dentistry practice.
    Hicks MJ; Barr ES; Flaitz CM
    J Pedod; 1986; 10(4):331-9. PubMed ID: 2980416
    [No Abstract]   [Full Text] [Related]  

  • 26. Evaluation of three pulpotomy medicaments in primary teeth.
    Markovic D; Zivojinovic V; Vucetic M
    Eur J Paediatr Dent; 2005 Sep; 6(3):133-8. PubMed ID: 16216093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessment of a novel alternative to conventional formocresol-zinc oxide eugenol pulpotomy for the treatment of pulpally involved human primary teeth: diode laser-mineral trioxide aggregate pulpotomy.
    Saltzman B; Sigal M; Clokie C; Rukavina J; Titley K; Kulkarni GV
    Int J Paediatr Dent; 2005 Nov; 15(6):437-47. PubMed ID: 16238654
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternative method of hemorrhage control in full strength formocresol pulpotomy.
    Thompson KS; Seale NS; Nunn ME; Huff G
    Pediatr Dent; 2001; 23(3):217-22. PubMed ID: 11447951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retrospective Study of the Survival Rates of Indirect Pulp Therapy Versus Different Pulpotomy Medicaments.
    Wunsch PB; Kuhnen MM; Best AM; Brickhouse TH
    Pediatr Dent; 2016 Oct; 38(5):406-411. PubMed ID: 28206897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative evaluation of formocresol and mineral trioxide aggregate as pulpotomy agents in deciduous teeth.
    Srinivasan D; Jayanthi M
    Indian J Dent Res; 2011; 22(3):385-90. PubMed ID: 22048576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiographic assessment of primary molar pulpotomies restored with resin-based materials.
    Guelmann M; McIlwain MF; Primosch RE
    Pediatr Dent; 2005; 27(1):24-7. PubMed ID: 15839391
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retrospective record review: reinforced zinc oxide-eugenol pulpotomy: a retrospective study.
    Hui-Derksen EK; Chen CF; Majewski R; Tootla RG; Boynton JR
    Pediatr Dent; 2013; 35(1):43-6. PubMed ID: 23635897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical study of ferric sulfate as a pulpotomy agent in primary teeth.
    Fei AL; Udin RD; Johnson R
    Pediatr Dent; 1991; 13(6):327-32. PubMed ID: 1843987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current pulp therapy options for primary teeth.
    Blanchard S; Boynton J
    J Mich Dent Assoc; 2010 Jan; 92(1):38, 40-1. PubMed ID: 20131727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical, radiographic, and histopathologic evaluation of Nd:YAG laser pulpotomy on human primary teeth.
    Odabaş ME; Bodur H; Bariş E; Demir C
    J Endod; 2007 Apr; 33(4):415-21. PubMed ID: 17368330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A histopathological comparison of pulpal response to formocresol and sodium hypochlorite used as pulpotomy medicaments: In primary teeth - A clinical trialA histopathological comparison of pulpal response to formocresol and sodium hypochlorite used as pulpotomy medicaments: In primary teeth - A clinical trial.
    Kola SR; Reddy NV; Sneha T; Reddy MA; Niharika P; Kumar PJ
    J Indian Soc Pedod Prev Dent; 2019; 37(2):198-204. PubMed ID: 31249186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic pulpotomies in primary molars with the formocresol technique. A clinical and histological follow-up.
    Magnusson BO
    Acta Odontol Scand; 1978; 36(3):157-65. PubMed ID: 277052
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light-cured calcium hydroxide vs formocresol in human primary molar pulpotomies: a randomized controlled trial.
    Zurn D; Seale NS
    Pediatr Dent; 2008; 30(1):34-41. PubMed ID: 18402097
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and radiographic success of (partial) pulpotomy and pulpectomy in primary teeth: A systematic review.
    Boutsiouki C; Frankenberger R; Krämer N
    Eur J Paediatr Dent; 2021 Dec; 22(4):273-285. PubMed ID: 35034465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of mineral trioxide aggregate and formocresol as pulp-capping agents in pulpotomized primary teeth.
    Agamy HA; Bakry NS; Mounir MM; Avery DR
    Pediatr Dent; 2004; 26(4):302-9. PubMed ID: 15344622
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.